Meeting
2014 ASCO Annual Meeting
Preoperative chemoradiation versus preoperative chemotherapy alone for esophageal cancer: Higher response rates but equivalent survival.
Authors
Brendon Matthew Stiles
Weill Cornell Medical College, New York, NY
Brendon Matthew Stiles , Abu Nasar , Subroto Paul , Paul Chinfai Lee , Jeffrey L. Port , Manish A. Shah , Nasser K. Altorki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 4071)
DOI
10.1200/jco.2014.32.15_suppl.4071
Abstract #
4071
Poster Bd #
158
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Unveiling survival strategies: The impact of treatment modalities on patients with esophageal cancer and the role of racial disparities.
First Author: Dani Ran Castillo
Poster
2021 Gastrointestinal Cancers Symposium
Impact of gender on treatment and survival of patients with esophageal cancer in the United States.
First Author: Camille Baumrucker
Poster
2017 Gastrointestinal Cancers Symposium
Effect of extending the original eligibility criteria for the “CROSS” neoadjuvant chemoradiotherapy on toxicity and survival in esophageal cancer.
First Author: Jan-Binne Hulshoff
Poster
2016 Gastrointestinal Cancers Symposium
Accuracy of clinical staging with EUS for early stage esophageal cancer: Are we denying patients beneficial neoadjuvant chemo-radiation?
First Author: Carrie Luu